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ABSTRACT
Background: Vitamin B-12 and folate are micronutrients essential
for normal embryogenesis. Vitamin B-12 insufficiency in pregnancy
is high in certain parts of the world, such as India, and although this
has been linked to low birth weight (LBW) in these populations, the
relation between vitamin B-12 and birth weight (BW) elsewhere is
unknown.
Objectives: We performed a systematic review to assess 1) the
worldwide prevalence of vitamin B-12 insufficiency in pregnancy
and 2) its association with BW.
Design: A search of 5 electronic databases was performed to iden-
tify eligible articles. Random-effects meta-analysis was conducted
according to geographic regions and pregnancy trimesters for the
prevalence subreview and by categorical measures of BW.
Results: A total of 57 and 23 articles were included for the prev-
alence and BW subreviews, respectively. The pooled estimates of
vitamin B-12 insufficiency were 21%, 19%, and 29% in the first,
second, and third trimesters, respectively, with high rates for the
Indian subcontinent and the Eastern Mediterranean. The large het-
erogeneity between studies was partially addressed by creating
a standardized score for each study (mean vitamin B-12 insuffi-
ciency O cutoff value), which internally corrected for geographic
region, trimester, and assay type. Twelve of the 13 longitudinal
studies included showed a decrease in mean or median vitamin
B-12 across trimesters. Pooled analysis showed nonsignificantly
lower maternal vitamin B-12 concentrations in LBW than in
normal-BW infants and higher odds of LBW with lower vitamin
B-12 values (adjusted OR: 1.70; 95% CI: 1.16, 2.50), but studies
from India largely contributed to the latter.
Conclusions: Our review indicates that vitamin B-12 insufficiency
during pregnancy is common even in nonvegetarian populations and
that concentrations of vitamin B-12 decrease from the first to the third
trimester. There is no consistent association between vitamin B-12
insufficiency and LBW. However, given the long-term risks of LBW,
this observation warrants further cohort studies and randomized con-
trolled trials. Am J Clin Nutr doi: 10.3945/ajcn.115.123083.
Keywords: vitamin B-12 insufficiency, pregnancy, low birth
weight, geographic variation, systematic review, meta-analysis
INTRODUCTION
Vitamin B-12, also known as cobalamin, is a micronutrient
essential for cellular growth, differentiation, and development
(1). Together with folic acid, vitamin B-12 is necessary for the
synthesis of DNA, RNA, lipids, and protein in the cellular cy-
toplasm (2, 3). More specifically, vitamin B-12 and folate are
necessary cofactors for the conversion of homocysteine to me-
thionine, the latter being an important methyl donor required for
the synthesis of neurotransmitters and phospholipids.
Vitamin B-12 insufficiency was previously perceived to be
a problem that affected the elderly, due to malnutrition or intrinsic
factor–mediated malabsorption (4), and has been related to
anemia, dementia, and cognitive dysfunction (5, 6). Although
hyperhomocysteinemia (most commonly due to vitamin B-12 or
folate deficiency) has been identified as an independent risk
factor for atherosclerotic vascular disease (7, 8), a systematic
review showed no definite association between vitamin B-12
insufficiency in adults and composite cardiovascular endpoints
(9). These 2 B-vitamins are, however, pivotal in normal em-
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bryogenesis, and therefore there is increasing attention on op-
timizing concentrations in young women in the periconceptional
period and pregnancy. Both low vitamin B-12 and folate con-
centrations have been associated with pregnancy complications
such as neural tube defects (NTDs),10 spontaneous abortion
(10), pre-eclampsia (11, 12), and preterm birth (13), with the
latter 2 conditions mediated in part by elevated homocysteine.
Folic acid supplementation is effective in reducing the risk of
NTDs by.40% (14), but because more than half of pregnancies
are unplanned, mandatory folic acid fortification of wheat flour
and cereal products was introduced in North America in 1997
and many other parts of the world in the early 2000s. This re-
sulted in a halving of NTDs due to folate deficiency over 10 y
(15). However, the number of NTDs attributable to vitamin B-12
deficiency has tripled during this time (16).
In addition, suboptimal vitamin B-12 concentrations in
pregnancy have been shown to be independently associated with
low birth weight (LBW) (17), an adverse lipid profile in neonates
(18), and higher insulin resistance in children (19). LBW or
small-for-gestational age (SGA) are outcomes of particular in-
terest because they are well-established surrogate markers for
metabolic disorders such as obesity, type 2 diabetes, and meta-
bolic syndrome in later life in many populations (20–22).
However, the relation between vitamin B-12 and birth weight
(BW) is far from established (23, 24). Most studies showing the
link between vitamin B-12 and LBW are from the Indian sub-
continent, where rates of both LBW/SGA and vitamin B-12
insufficiency are high (19, 25, 26). The high prevalence of vi-
tamin B-12 insufficiency in India has been attributed to vege-
tarianism (i.e., no consumption of animal products except for
dairy) and infrequent meat consumption in omnivores (i.e.,
consumption of small quantities of nonvegetarian food less often
than alternate days) (19, 27). However, vitamin B-12 in-
sufficiency has also been found in other countries where vege-
tarianism is rare, such as in Brazil and Turkey (28, 29). The aims
of our systematic review and meta-analysis are to evaluate the
prevalence of vitamin B-12 insufficiency in pregnancy across
a worldwide population and assess whether this is associated with
LBW and/or SGA.
METHODS
This systematic review comprises 2 subreviews: 1) prevalence
of vitamin B-12 insufficiency and 2) vitamin B-12 insufficiency
and BW. These subreviews will be divided accordingly where
appropriate in the following sections.
Sources of data
Published guidelines on reporting systematic reviews and
meta-analysis of observational studies [MOOSE (Meta-analysis
of Observational Studies in Epidemiology) guidelines] were
followed (30). A comprehensive literature search in 5 biblio-
graphic databases was conducted for the prevalence subreview:
MEDLINE/PubMed (National Library of Medicine and NIH;
http://www.ncbi.nlm.nih.gov/pubmed/), EMBASE (the Excerpta
Medica database; http://ovidsp.tx.ovid.com/), Global Health
(CABI; https://www.ebscohost.com/academic/global-health/),
CAB (Commonwealth Agricultural Bureau database; http://
www.cabdirect.org/), and CINAHL (Cumulative Index to
Nursing and Allied Health Literature; http://www.ebscohost.
com/). For the BW subreview, 4 databases were used, namely
MEDLINE/PubMed, EMBASE, Global Health, and Scopus
(Elsevier; http://www.scopus.com/). All databases were searched
from inception until December 2014. We also examined ref-
erence lists of key publications for further articles. When need-
ed, the authors were contacted by e-mail for more complete
information.
Search criteria
For the prevalence subreview, a search strategy based on the
following keywords and medical subject headings (MeSH) was
used: “cobalamin,” “vitamin B12,” “vitamin B12 insufficiency,”
“vitamin B12 deficiency,” “methylmalonic acid,” “holo-
transcobalamin,” “homocysteine,” “pregnancy,” and “pregnant
women.” Search words were combined by using Boolean op-
erators (AND, OR). A similar search string was used in all
bibliographic databases. Studies conducted in pregnant women
(aged 18–45 y) at any trimester, including delivery, which re-
ported the prevalence of vitamin B-12 insufficiency with clearly
defined cutoffs were included. Only results from the trimesters
in which vitamin B-12 values were available from at least
50 women are reported.
The keywords and MeSH used for the BW subreview included
the following: “cobalamin,” “vitamin B12 insufficiency,” “vitamin
B12 deficiency,” “methylmalonic acid,” “holotranscobalamin,”
“homocysteine,” “pregnancy outcome,” “birth weight,” “intrauterine
growth retardation,” and “small for gestational age.” An iden-
tical approach to that described above was used for combining
search words.
Eligibility criteria
Both longitudinal and cross-sectional observational studies
conducted in the community or hospital setting in pregnant
women (aged 18–45 y) without any major comorbidities were
included. We restricted the search to studies conducted in human
subjects and published in the English language in peer-reviewed
journals. If the results of a study were reported in .1 publica-
tion, the study with the most complete information pertaining to
our review’s outcomes was used. If these were identical, the
study published earlier was included. The following types of
studies were excluded: randomized controlled trials in which
vitamin B-12 supplementation was given as part of the study
design, case-control studies, and studies conducted exclusively
in mothers with comorbidities (e.g., HIV, post–bariatric sur-
gery). In addition, we excluded studies that were designed
specifically to look at pregnancies with NTDs, intrauterine
growth retardation (IUGR), early pregnancy loss, and anemia;
however, if the studies were conducted in healthy pregnant
women with no previous medical history and reported rates of
anemia in their results, they were included. For the BW subre-
view, we included studies that reported vitamin B-12 results
from maternal or cord blood and offspring BW.
10Abbreviations used: BW, birth weight; IUGR, intrauterine growth re-
striction; LBW, low birth weight; NTD, neural tube defect; SGA, small-
for-gestational age.
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Data extraction
Level 1 screening of initial database search results (titles and
abstracts) was independently performed by at least 2 reviewers
(NS and SBR) according to the inclusion and exclusion criteria.
Level 2 screening was conducted by reviewing the full manu-
scripts of the articles. Two reviewers (NS and SBR) in-
dependently extracted the study characteristics onto predesigned
forms that included information on the study population and
methods, vitamin B-12 values, and BW outcomes. Any dis-
crepancy in data extraction was resolved by consensus and by
consulting a third reviewer (PS) when necessary.
Data synthesis
For the prevalence subreview, we analyzed and reported the
results of the systematic review according to the 3 trimesters of
pregnancy to ensure like-for-like comparison. It is well known
from longitudinal studies that there is a progressive decline in
vitamin B-12 during the course of pregnancy (31, 32), which
reaches a nadir toward the end of the third trimester (33). To
assess the impact of geography on the worldwide prevalence of
vitamin B-12 insufficiency, the broad WHO region classification
was used (i.e., Africa, Americas, South East Asia, Europe,
Eastern Mediterranean, and Western Pacific) (34). However, we
further divided the Americas and South East Asia regions into
North America and Central/South America and Indian sub-
continent and South East/East Asia, respectively, in an attempt to
bring together the populations on the basis of dietary habits,
vegetarianism, and consumption of animal products (4).
For the BW subreview, the included studies reported 3 dif-
ferent types of effect sizes, namely the following: 1) odds of
having an adverse-BW outcome below a threshold of maternal/
cord vitamin B-12, 2) comparison of mean/median maternal/
cord vitamin B-12 values between adverse and normal BWs, and
3) the effect of maternal/cord vitamin B-12 as a linear variable
on BW (regression coefficient or correlation coefficient). Ad-
verse-BW outcome was defined as LBW (BW ,2500 g) (26),
SGA (BW ,10th centile for gestational age), IUGR (estimated
fetal weight ,10%) (35), or as the lowest tertile or quartile of
BW in the included studies.
Statistical analysis
Prevalence subreview
To estimate the pooled estimates of the vitamin B-12 in-
sufficiency rate per trimester, we obtained an estimate from each
study of the proportion of pregnant women with vitamin B-12
concentrations below the cutoff defined in that study. Subgroup
analysis was undertaken for the studies from the second and third
trimesters to determine whether the prevalence of vitamin B-12
insufficiency in pregnancy varied according to the geographic
areas. Statistical heterogeneity was calculated by using the
I2 statistic (36). A random-effects meta-analysis (37) was un-
dertaken by using STATA version 13 software (StataCorp) (38).
We assessed publication bias by using a funnel plot and Egger’s
and Begg’s tests to find out whether there was a bias toward
publication of studies with positive results among the smaller
studies (results not shown).
To correct for differences in the vitamin B-12 measurement
assays and cutoffs used by the studies, we calculated a stan-
dardized score by dividing the mean vitamin B-12 concentration
used in the study by the cutoff used to define insufficiency in that
study (mean vitamin B-12 O insufficiency cutoff value). In the
studies in which a median vitamin B-12 value was reported, it
was used to estimate the mean when sample sizes were large
(39). Stepwise linear regression was then performed to de-
termine the predictors of the percentage of vitamin B-12 in-
sufficiency in a model that included the trimester of sampling,
assay type, and geographic region. Log-transformed standard-
ized scores were used for this because the variable was not
normally distributed. SPSS version 22 was used for the analysis
(40).
BW subreview
The software ReviewManager (41) was used to conduct meta-
analyses from the included studies. We obtained an estimate from
each study of the adjusted ORs with 95% CIs by using a random-
effects model. Statistical heterogeneity was calculated by using
the I2 statistic (36). Adjusted outcome measures were tabulated
where these were reported. Continuous effect measures data
were expressed as mean 6 SD differences of vitamin B-12
between infants of LBWor the equivalent (termed “adverse birth
weight outcome cases”) and normal-BW outcome. Pooled
analyses were not done for the studies that reported vitamin B-
12 and BW as linear variables, because there was too much
heterogeneity in the reporting of the independent variable and
outcome (e.g., some reporting unit values and others SD scores).
Risk of bias and quality of evidence
The methodologic quality assessment of the studies was per-
formed by using a checklist for cohort studies adapted from the
Scottish Intercollegiate Guidelines Network (42). The quality as-
sessment focused on evaluating how minimal the risk of bias was in
study reporting by using 14 key criteria from the checklist (Sup-
plemental Table 1). However, for certain cross-sectional studies
that reported only the point prevalence of vitamin B-12 in-
sufficiency, only 12 relevant criteria were used (criteria relating to
dropout rate and comparison between full participants and those
lost to follow-up were not used, because these were not relevant).
The overall study quality grade was calculated as per standard
guidelines according to the proportion of total criteria fulfilled (42).
RESULTS
Prevalence of vitamin B-12 insufficiency
Study characteristics
The electronic database search yielded 4742 citations, of
which 153 were selected for full-text review (Figure 1A). There
were 6 studies identified from the full-text review that reported
vitamin B-12 insufficiency rates during pregnancy but without
specifying a trimester (43–46) or clearly stating the number of
women sampled per trimester (47, 48). These studies were not
included in further analysis.
A total of 57 studies (19, 28, 29, 31, 49–101) met all of the
inclusion criteria and comprised 16 longitudinal studies (n = 34
results) and 41 cross-sectional studies, giving a total of 75 results.
Details of these studies, including the country in which the field-
work was done, the proportion of vitamin B-12 supplement or
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multivitamin use, vitamin B-12 assay method, and insufficiency
rates, are presented in Table 1. For the setting of the study, they
were broadly categorized into a community or hospital setting
(including health centers) to reflect where the population was
sampled. In the first, second, and third trimesters, there were 12, 21,
and 42 results, which were obtained by sampling 10,474, 8621, and
11,667 pregnant women, respectively.
Prevalence of vitamin B-12 insufficiency in pregnancy
The overall prevalence of maternal vitamin B-12 insufficiency
during pregnancy from all of the studies, across all 3 trimesters,
was 25%.When analyzing by trimester, the rates were 21%, 19%,
and 29% for the first, second, and third trimesters, respectively
(Figures 2–4).
Of the first-trimester studies, there was insufficient represen-
tation from all of the geographic regions to do a comprehensive
subgroup analysis. The 4 studies from the Indian subcontinent
showed a high insufficiency rate (pooled estimate: 32%; Figure
2). This observation was once again seen in the second trimester,
with the pooled insufficiency rate from the Indian subcontinent
increasing to 64% (Figure 3). Apart from North America, South
East/East Asia, and Europe, the other geographic regions were
also poorly represented in the second trimester, but there were
notably high insufficiency rates of 59%, 49%, and 46% found
from studies carried out in Venezuela (31), Turkey (28), and
South Korea (88), respectively.
Of the studies included in the third trimester, the pooled in-
sufficiency rate of the studies from the Indian subcontinent was
60%. An additional striking finding was the pooled insufficiency
rate of 65% (I2 = 95%) (Figure 4) (28, 52, 65, 77, 93) from the 5
studies in the Eastern Mediterranean region. On the contrary,
insufficiency rates of ,8% were found in 2 studies conducted in
Thailand and Sudan, where the authors attributed the low rates
of insufficiency to the consumption of fish and animal/fermented
products, respectively (although details of dietary intake were
not provided) (49, 50).
Mean vitamin B-12 concentrations across trimesters
Eleven studies included in this review reported mean vitamin
B-12 results through the course of pregnancy and 2 studies
reported median vitamin B-12 results longitudinally. Ten of the
11 studies that reported the mean showed a consistent decrease
in vitamin B-12 concentrations from the first to the third (91,
95), from the second to the third (28, 45, 46, 81, 87), and from
the first to the second to the third (85, 96, 98) trimesters. The
exception was the study by Marzan et al. (83), which showed
a marginal increase in mean vitamin B-12 concentrations across
the pregnancy (266, 270, and 286 pmol/L in the first, second,
and third trimesters, respectively), despite the participants not
FIGURE 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram showing the study selection process. (A)
Prevalence of B-12 insufficiency in pregnancy subreview and (B) B-12 insufficiency and birthweight subreview. B12, vitamin B-12; BW, birth weight; RCT,
randomized controlled trial.
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TABLE 1
Prevalence of vitamin B-12 insufficiency during pregnancy: key study characteristics and results1
First author, publication year
(ref), country, year of field
study
Study design,
number of
participants with
vitamin B-12
results
Setting of study
population, response
rate
Vitamin B-12
supplement or
multivitamin
use, %
Vitamin B-12 cutoff,
pmol/L
Vitamin B-12
insufficiency,
%
Vitamin B-12,
pmol/L
First trimester (n = 12)
Microbiological assay
Whiteside, 1968 (a)
(98), Australia, N/R
L, 56 Hospital, N/R N/R ,74 5 217
Roberts, 1973 (a) (91),
England, 1971
L, 320 Hospital, N/R N/R ,118 35 165 6 84.93
Jiang, 2005 (74),
Nepal, 1998–2001
CS, 1158 Community, 89%
consented
None ,150 28.3 237.1 6 138.3
Murphy, 2007 (a) (85),
Spain, 1992–1996
L, 88 Hospital, N/R 272 ,150 0 267 (144, 449)4
Radioimmunoassay
García-Casal, 2005 (a)
(31), Venezuela,
2001–02
CS, 129 Hospital, N/R N/R ,148 43.4 N/R
Ray, 2008 (90),
Canada, 2007
CS, 3734 N/R, N/R N/R ,125 8.5 249 (244, 255)5
Chemiluminescence
Ko¨sxu¨sx, 2012 (78),
Turkey, N/R
CS, 228 Hospital, N/R N/R ,156 12.5 200 (95.6)6
Dwarkanath, 2013 (60),
India, N/R
L, 1838 Hospital, 73%
consented
None ,150 32 N/R
Heppe, 2013 (67),
Netherlands, 2002–
2006
CS, 2173 Hospital, N/R N/R ,150 26 175 (100)6
Samuel, 2013 (92),
India, 2008–2010
CS, 352 Hospital, 88%
consented
None ,150 51.1 149 (109, 205)6
Shamim, 2013 (94),
Bangladesh, 2001–
2007
CS, 285 Community, N/R N/R ,150 19.6 206.3 6 84.5
Assay method not
described
Shields, 2011 (a) (95),
Scotland, 2008–2009
CS, 113 Hospital, N/R N/R ,156 16 215
Second trimester (n = 21)
Microbiological assay
Lowenstein, 1960 (a)
(81), Canada, N/R
L, 59 N/R, N/R N/R ,148 15.2 235 6 101
Whiteside, 1968 (b)
(98), Australia, N/R
L, 50 Hospital, N/R N/R ,74 25 127
Jacob, 1976 (72),
USA, 1972–1974
CS, 182 Hospital, 100%
consented
20 ,111 4.5 303
Murphy, 2007 (b) (85),
Spain, 1992–1996
L, 90 Hospital, N/R 272 ,150 0 230 (123, 432)4
Yajnik, 2008 (a) (19),
India, 1994–1996
L, 638 Community, 92%
consented
N/R ,150 60 135 (103, 175)6
Katre, 2010 (75),
India, 2004–2006
L, 163 Hospital, 97.3%
consented
292 ,150 73 119 (87, 161)6
Radioimmunoassay
Marzan, 1971 (a) (83),
Philippines, N/R
CS, 100 Hospital, N/R None ,59 1.5 270.1 6 79
Areekul, 1976 (a) (50),
Thailand, N/R
CS, 71 Hospital, N/R N/R ,111 7 All trimesters:
211 6 106
Knight, 1991 (a) (76),
USA, 1985–1990
L, 108 Hospital, N/R 912 ,148 7 N/R
Bruinse, 1995 (a) (56),
Netherlands, N/R
L, 70 Hospital, N/R None ,180 0 N/R
(Continued)
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TABLE 1 (Continued )
First author, publication year
(ref), country, year of field
study
Study design,
number of
participants with
vitamin B-12
results
Setting of study
population, response
rate
Vitamin B-12
supplement or
multivitamin
use, %
Vitamin B-12 cutoff,
pmol/L
Vitamin B-12
insufficiency,
%
Vitamin B-12,
pmol/L
Ac¸kurt, 1995 (a) (28),
Turkey, 1991
L, 129 Hospital, 66%
responded to
invitation
35 ,111 48.8 140.8 6 105
Pagán, 2002 (a) (87),
USA, 1986–1988
L, 285 N/R, N/R N/R ,148 0.35 357 6 131
Park, 2004 (88),
South Korea, N/R
CS, 89 Hospital, N/R 42 ,258 46.1 N/R
García-Casal, 2005 (b)
(31), Venezuela,
2001–2002
CS, 430 Hospital, N/R N/R ,148 58.6 N/R
Li, 2008 (80),
Bangladesh, 2002
L, 753 Community, 78%
consented
N/R ,185 60 N/R
Chemiluminescence
Takimoto, 2007 (a) (96),
Japan, 2001–2003
L, 77 Hospital, N/R N/R ,148 8 301 6 96
Goedhart, 2011 (64),
Netherlands, 2003–
2004
CS, 2921 Community, 35%
consented
N/R ,148 6 N/R
Enzyme immunoassay
House, 2000 (70),
Canada, 1996–1997
CS, 1424 N/R, N/R N/R ,130 25.3 180 (130, 240)6
Milman, 2006 (a) (84),
Denmark, 1995–1996
L, 406 N/R, N/R 342 ,150 15 225 (118, 381)7
Wu, 2013 (a) (99),
Canada, N/R
L, 264 Hospital, N/R N/R ,148 10 287 6 126
Others
Hinderaker, 2002 (68),
Tanzania, 1995–1996
CS, 312 Hospital, 78%
consented
N/R HPLC: ,150 16.7 N/R
Third trimester (n = 42)
Microbiological assay
Lowenstein, 1960 (b)
(81), Canada, N/R
L, 252 N/R, N/R N/R ,148 19 221 6 126
Zachau-Christiansen,
1962 (101),
Denmark, N/R
CS, 365 Hospital, N/R N/R ,111 17 177
Roberts, 1973 (b) (91),
England, 1971
L, 119 Hospital, N/R N/R ,118 48 134 6 70.9
Yusufji, 1973 (100),
India, N/R
CS, 998 Hospital, N/R N/R ,103 52 117 6 90
Baker, 1975 (51),
USA, N/R
CS, 174 N/R, N/R 762 ,59 23 85 6 832
Osifo, 1976 (86),
Nigeria, N/R
CS, 50 N/R, N/R N/R ,148 40 208 6 123
Bjørke Monsen, 2001
(54), Norway, 1996–
1997
CS, 169 Hospital, N/R 362 ,150 15 245 (175, 323)6
Murphy, 2007 (c) (85),
Spain, 1992–1996
L, 90 Hospital, N/R 272 ,150 0 224 (117, 444)4
Pathak, 2007 (89),
India, N/R
CS, 266 Community, 94%
consented
N/R ,148 74.1 N/R
Yajnik, 2008 (b) (19),
India, 1994–1996
L, 594 Community, 92%
consented
N/R ,150 71 122 (94, 160)6
Krishnaveni, 2009 (79),
India, 1997–1998
CS, 774 Hospital, N/R 312 ,150 43 162 (123, 221)6
Radioimmunoassay
Marzan, 1971 (b) (83),
Philippines, N/R
CS, 57 Hospital, N/R None ,59 0 286.3 6 86
(Continued)
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TABLE 1 (Continued )
First author, publication year
(ref), country, year of field
study
Study design,
number of
participants with
vitamin B-12
results
Setting of study
population, response
rate
Vitamin B-12
supplement or
multivitamin
use, %
Vitamin B-12 cutoff,
pmol/L
Vitamin B-12
insufficiency,
%
Vitamin B-12,
pmol/L
Cole, 1974 (57),
Australia, N/R
CS, 130 Hospital, N/R N/R ,148 12.3 272.3
Colman, 1975 (58),
South Africa, N/R
CS, 106 Hospital, N/R N/R ,295 0.9 524 6 165
Areekul, 1976 (b) (50),
Thailand, N/R
CS, 100 Hospital, N/R N/R ,111 13 All trimesters:
211 6 106
Fréry, 1992 (61),
France, N/R
CS, 188 Hospital, N/R N/R ,148 27.6 175 (74, 397)5
Giugliani, 1984 (63),
Brazil, N/R
CS, 51 Hospital, 100% 512 ,165 21.6 251 6 108
Ho, 1987 (69),
Taiwan, N/R
CS, 221 Hospital, N/R None ,110 3.6 228.6 6 157.3
Knight, 1991 (b) (76),
USA, 1985–1990
L, 218 Hospital, N/R 912 ,148 11.2 318 6 216
Black, 1994 (55),
Mexico, 1985–1987
CS, 85 Community, N/R N/R ,74 15 228 6 451
Ac¸kurt, 1995 (b) (28),
Turkey, 1991
L, 87 Hospital, 66%
responded to
invitation
35 ,111 80.9 94.6 6 107.8
Bruinse, 1995 (b) (56),
Netherlands, N/R
L, 70 Hospital, N/R None ,180 0 N/R
Pagán, 2002 (b) (87),
USA, 1986–1988
L, 285 N/R, N/R N/R ,148 2.1 285 6 100
Ma, 2004 (82),
China, 1999–2000
CS, 1019 Hospital, N/R None ,148 10.5 N/R
García-Casal, 2005 (c)
(31), Venezuela,
2001–2002
CS, 301 Hospital, N/R N/R ,148 68.5 N/R
Hall, 2007 (66),
Bangladesh, 2004–
2005
CS, 95 Hospital, N/R N/R ,185 58.9 180.0 6 71.5
Gibson, 2008 (62),
Ethiopia, N/R
CS, 83 Community, N/R N/R ,150 23 268 (152, 372)6
Chemiluminescence
Schulpis, 2004 (93),
Greece, 1999–2002
CS, 1933 Hospital, N/R None ,170 52.7 N/R
Koc, 2006 (77),
Turkey, N/R
CS, 180 Hospital, N/R 19 ,118 72 95.9 6 45.5
Takimoto, 2007 (b) (96),
Japan, 2001–2003
L, 82 Hospital, N/R N/R ,148 16 265 6 95
Barbosa, 2008 (53),
Brazil, 2001–2003
CS, 275 Hospital, N/R None ,179 75 N/R
Hussein, 2009 (71),
Egypt, N/R
CS, 84 Hospital, N/R N/R ,150 46.4 185.3 6 113
Vanderjagt, 2009 (97),
Nigeria, N/R
CS, 98 Hospital, N/R None ,148 12.2 208 (25, 739)8
Halicioglu, 2012 (65),
Turkey, 2008
CS, 208 Hospital, 88%
consented
572 ,118 47.6 120 (N/R)6
Balcı, 2014 (52),
Turkey, N/R
CS, 72 N/R, N/R None ,148 70.8 120 6 53.1
Enzyme immunoassay
Guerra-Shinohara, 2004
(29), Brazil, N/R
CS, 119 Hospital, N/R N/R ,132 52.9 130 (122, 138)5
Milman, 2006 (b) (84),
Denmark, 1995–1996
L, 256 N/R, N/R 342 ,150 42.6 161 (71, 284)7
Wu, 2013 (b) (99),
Canada, N/R
L, 220 Hospital, N/R N/R ,148 23 224 6 96.2
(Continued)
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taking vitamin B-12 or multivitamin supplements. The 2 studies
that reported median vitamin B-12 values showed a decrease of
13 and 64 pmol/L between the second and third trimesters
(19, 84).
Standardized score
A total of 32 of the 57 studies reported mean vitamin B-12
values in addition to the insufficiency rates. Ten of these were
longitudinal studies, providing results from .1 trimester; thus,
a total of 43 results were available. In addition, 12 studies re-
ported the median values that were used to estimate the mean.
Two of these were longitudinal, yielding a total of 14 results.
Combining the above 2 studies, we obtained 57 standardized
scores (ratio of mean O cutoff). Details of these studies with
their standardized scores and corresponding vitamin B-12 in-
sufficiency rates are shown in Table 2.
Linear regression was performed to test the degree towhich the
standardized score was a predictor of percentage of vitamin B-12
insufficiency reported in each study, in a model that included
trimester, geographic region, and assay type. Two outlying results
from a single study that gave very high standardized scores of
.4.5 (due to a very low vitamin B-12 cutoff threshold of
59 pmol/L) were excluded (83). The model explained 72% of
variance in the percentage insufficiency, and the standardized
score was the only significant predictor of the former (adjusted
B-coefficient: 2136.5; 95% CI: 2159.7, 2113.3; P , 0.001)
(Supplemental Figure 1). This confirms that, after internal
correction for the assay type and cutoff, it was the same group of
studies with the lower standardized scores (from specific geo-
graphic regions, namely the Indian subcontinent and Eastern
Mediterranean) that also found higher prevalence rates of vitamin
B-12 insufficiency, giving more weight to the results seen in the
forest plots (Figures 2–4).
Study quality assessment
Studies were of differing quality, and the detailed quality
assessments are shown in Supplemental Table 2. A total of 23
of the 57 of the studies were of good quality with minimal bias
in reporting, a further 28 were of moderate quality, and 6 were
of poor quality. When the breakdown of assessment criteria was
looked at, most studies had a clearly defined question and
outcomes but performed poorly in reporting the proportion of
eligible participants consenting, the reliability and validity of
biochemical assays used, and in accounting for confounders
in analysis.
Vitamin B-12 insufficiency and BW
Study characteristics
A total of 1900 citations were obtained from the electronic
database searches and by reviewing references of articles (Figure
1B). A total of 947 records were shortlisted for title and abstract
screening, of which 148 full-text reviews were performed. A total of
23 studies met all of the inclusion criteria after full-text review and
were included in the final analysis (23–25, 29, 60, 61, 87, 96, 102–
116). Tables 3–5 provide the characteristics of these studies and
their results. The studies reported the association between maternal
or cord vitamin B-12 concentrations and LBW in 3 different ways:
1) logistic regression to analyze the OR of having an adverse-BW
outcome (e.g., LBW, SGA, or IUGR) with low vitamin B-12
concentrations (n = 5; Table 3), 2) comparison of mean/median
vitamin B-12 values between adverse-BW cases and normal-BW
TABLE 1 (Continued )
First author, publication year
(ref), country, year of field
study
Study design,
number of
participants with
vitamin B-12
results
Setting of study
population, response
rate
Vitamin B-12
supplement or
multivitamin
use, %
Vitamin B-12 cutoff,
pmol/L
Vitamin B-12
insufficiency,
%
Vitamin B-12,
pmol/L
Others
Abdelrahim, 2009 (49),
Sudan, 2007–2009
CS, 55 Hospital, N/R N/R Immunofluorescence:
,111
1.1 159.4 6 66.5
Assay method not described
Cook, 1971 (59),
Latin America, N/R
CS, 899 N/R, N/R N/R ,59 15.4 N/R
Shields, 2011 (b) (95),
Scotland, 2008–2009
L, 77 Hospital, N/R N/R ,156 60 153
Jacquemyn, 2014 (73),
Belgium, 2011
CS, 78 Hospital, N/R 762 ,150 13 244 6 93.9
1Key study characteristics and results from the 57 included studies classified according to the trimesters of pregnancy and vitamin B-12 measurement
assay are presented. The lowercase letters in parentheses in the first column indicate the order of appearance in the table for studies that reported results from
.1 trimester. CS, cross-sectional; L, longitudinal (i.e., the same participants had .1 vitamin B-12 measurement during pregnancy); N/R, not reported; ref,
reference.
2The study states explicitly that the women consumed vitamin B-12 supplements or multivitamins containing vitamin B-12.
3Mean 6 SD (all such values).
4Geometric mean; 10th, 90th centile in parentheses.
5Geometric mean; 5th, 95th centile in parentheses.
6Median; 25th, 75th centile or IQR in parentheses.
7Median; 5th, 95th centile in parentheses.
8Median; minimum, maximum in parentheses.
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controls (n = 15; Table 4), and 3) linear regression to study the
association between vitamin B-12 and BW as continuous variables
(n = 10; Table 5). Six studies reported their results by using
a combination of the above 3 methods (23–25, 103, 108, 114) and
were included as appropriate.
Odds of SGA or LBW with low vitamin B-12 concentrations
Five studies across the trimesters (23–25, 60) and cord blood
(114) (8 results) reported the ORs of SGA or LBW with lower
vitamin B-12 concentrations compared with higher concentra-
tions (Table 3). Meta-analysis (n = 1482; 598 cases, 884 con-
trols) of all of these studies showed that the OR of having an
SGA/LBW infant was 1.70 (95% CI: 1.16, 2.50) with lower
vitamin B-12 concentrations (Figure 5).
There were too few results from different countries and tri-
mesters to provide subgroup analysis. Therefore, we conducted
only the following 3 analyses: 1) removal of the study reporting
only cord blood vitamin B-12 concentrations (114) [because
vitamin B-12 is actively transported across the placenta (117)
and is expected to be higher than that of maternal vitamin B-12],
2) combining the 6 results from India (from 3 studies) (25, 60,
114) because of the high prevalence of both vitamin B-12 in-
sufficiency and SGA/LBW infants (26), and 3) removal of the
Muthayya et al. (25) study because it reported large effect sizes
and contributed 21.5% to the pooled analysis. The ORs (95%
CIs) were 1.59 (1.07, 2.36), 2.42 (1.50. 3.92), and 1.23 (0.90,
1.67), respectively, in these subgroup analyses. There were only
2 other results (from Australia and Holland), which did not show
any association between vitamin B-12 and BW (23, 24).
Differences in mean/median vitamin B-12 concentrations and
adverse BW
Fifteen studies reported either mean or median vitamin B-12
values between normal-BWand LBW/SGA groups. There were 8
cross-sectional and 7 longitudinal studies, yielding a total of 25
results (Table 4). Two subgroup meta-analyses by maternal con-
centrations (n = 1969; 487 cases and 1482 controls; 14 results)
(Figure 6A) and cord blood concentrations (n = 896; 382
FIGURE 2 Meta-analysis of maternal vitamin B-12 insufficiency in the first trimester of pregnancy separated by subgroups of geographic regions (n = 12
results). Open diamonds represent the pooled proportions for each subgroup and the overall proportion for the trimester, and the solid diamonds in each study
denote the proportion for that study (horizontal lines represent 95% CIs). The I2 values refer to the statistical heterogeneity within each subgroup and the
whole trimester combined. A random-effects model using generic inverse variance showed a pooled proportion insufficiency rate of 0.21 (0.14, 0.30). Studies
which have reported results from .1 trimester have a lowercase letter in parentheses in the study reference to indicate their order of appearance in the Forest
plots. ES, effect size; N/A, not applicable.
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cases and 514 controls; 6 results) (Figure 6B) were conducted.
Although the pooled estimates showed lower maternal vitamin
B-12 concentrations in the adverse-BW group (particularly in
the second trimester), these were not significant (Figure 6A).
Similarly, the pooled meta-analyses of cord blood vitamin
B-12 concentrations were not different between the BW
groups (Figure 6B).
Three other studies (n = 880; 430 cases and 450 controls; 5
results) from the third trimester and cord blood showed differ-
ences in vitamin B-12 concentrations between the normal- and
adverse-BW groups in terms geometric mean (107, 116), or
mean difference in SD compared to the appropriate normal mean
for gestation (102) (Table 4). One study showed a nonsignificant
lower geometric mean vitamin B-12 concentration in the third
trimester in SGA infants (116), but none of the other studies
showed the positive association expected. These studies were not
included in the pooled analysis of Figure 6A, B because the
effect sizes could not be converted to a mean 6 SD value.
Effect of vitamin B-12 concentrations across the spectrum on BW
Ten studies examined vitamin B-12 and BW as continuous
variables (Table 5). In cases in which the studies performed both
unadjusted linear correlations and adjusted regression coefficients
we reported the latter (as B- or b-coefficients), but if only un-
adjusted correlations were carried out, we reported the former (as
r coefficients). One study showed a significant positive correlation
FIGURE 3 Meta-analysis of maternal vitamin B-12 insufficiency in the second trimester of pregnancy separated by subgroups of geographic regions (n =
21 results). Open diamonds represent the pooled proportions for each subgroup and the overall proportion for the trimester, and the solid diamonds in each
study denote the proportion for that study (horizontal lines represent 95% CIs). The I2 values refer to the statistical heterogeneity within each subgroup and the
whole trimester combined. A random-effects model using generic inverse variance showed a pooled proportion insufficiency rate of 0.19 (0.10, 0.30). Studies
which have reported results from .1 trimester have a lowercase letter in parentheses in the study reference to indicate their order of appearance in the Forest
plots. ES, effect size; N/A, not applicable.
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(17), and 9 showed no association between vitamin B-12 and
BW [2 positive but nonsignificant (103, 108), 5 negative (24, 29,
61, 87, 105), and 2 showed varying associations at different time
points (96, 113)].
Study quality assessment
Nine of the 23 studies were of good quality with minimal bias
in reporting, a further 10 were of moderate quality, and 4 were of
poor quality (Supplemental Table 3). Although the studies
generally did well in reporting an appropriate study question and
describing the source population, more than half did not report
the number of eligible participants who consented or the rates of
mothers/neonates lost to follow-up or performed a comparison
between participants with available and missing data.
DISCUSSION
Prevalence of vitamin B-12 insufficiency
One of the striking findings of our systematic review was the
high rate of vitamin B-12 insufficiency among certain populations
FIGURE 4 Meta-analysis of maternal vitamin B-12 insufficiency in the third trimester of pregnancy separated by subgroups of geographic regions (n = 42
results). Open diamonds represent the pooled proportions for each subgroup and the overall proportion for the trimester, and the solid diamonds in each study
denote the proportion for that study (horizontal lines represent 95% CIs). The I2 values refer to the statistical heterogeneity within each subgroup and the
whole trimester combined. A random-effects model using generic inverse variance showed a pooled proportion insufficiency rate of 0.29 (0.21, 0.37). Studies
which have reported results from .1 trimester have a lowercase letter in parentheses in the study reference to indicate their order of appearance in the Forest
plots. ES, effect size; N/A, not applicable.
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TABLE 2
Calculated standardized scores and corresponding vitamin B-12 insufficiency rates1
First author, year (reference) Trimester (n)
Mean vitamin
B-12, pmol/L
Vitamin B-12
cutoff, pmol/L
Vitamin B-12
insufficiency, % Standardized score
Katre, 2010 (75) 2 (163) 1192 150 73 0.79
Koc, 2006 (77) 3 (180) 96 118 72 0.81
Balcı, 2014 (52) 3 (72) 120 148 70.8 0.81
Yajnik, 2008 (b) (19) 3 (594) 1222 150 71 0.81
Ac¸kurt, 1995 (b) (28) 3 (87) 95 111 80.9 0.85
Yajnik, 2008 (a) (19) 2 (638) 1352 150 60 0.9
Hall, 2007 (66) 3 (95) 180 185 58.9 0.97
Guerra-Shinohara, 2004 (29) 3 (117) 130 132 52.9 0.98
Shields, 2011 (b) (95) 3 (77) 153 156 60 0.98
Samuel, 2013 (92) 1 (352) 1492 150 51.1 1
Halicioglu, 2012 (65) 3 (208) 1202 118 47.6 1.02
Milman, 2006 (b) (84) 3 (256) 1612 150 42.6 1.07
Krishnaveni, 2009 (79) 3 (774) 1622 150 43 1.08
Roberts, 1973 (b) (91) 3 (119) 134 118 48 1.14
Yusufji, 1973 (100) 3 (998) 117 103 52 1.14
Heppe, 2013 (67) 1 (2173) 1752 150 26 1.17
Fréry, 1992 (61) 3 (188) 175 148 27.6 1.18
Hussein, 2009 (71) 3 (84) 185 150 46.4 1.24
Ac¸kurt, 1995 (a) (28) 2 (129) 141 111 48.8 1.27
Ko¨sxu¨sx, 2012 (78) 1 (228) 2002 156 12.5 1.28
Shields, 2011 (a) (95) 1 (113) 215 156 16 1.38
Shamim, 2013 (94) 1 (285) 206 150 19.6 1.38
House, 2000 (70) 2 (1424) 1802 130 25.3 1.38
Roberts, 1973 (a) (91) 1 (320) 165 118 35 1.4
Osifo, 1976 (86) 3 (50) 208 148 40 1.41
Vanderjagt, 2009 (97) 3 (98) 2082 148 12.2 1.41
Baker, 1975 (51) 3 (174) 85 59 23 1.44
Abdelrahim, 2009 (49) 3 (55) 159 111 1.1 1.44
Lowenstein, 1960 (b) (81) 3 (252) 221 148 19 1.49
Murphy, 2007 (c) (85) 3 (84) 224 150 0 1.49
Milman, 2006 (a) (84) 2 (406) 2252 150 15 1.5
Wu, 2013 (b) (99) 3 (220) 224 148 23 1.51
Giugliani, 1984 (63) 3 (165) 251 165 21.6 1.52
Murphy, 2007 (b) (85) 2 (90) 230 150 0 1.53
Jiang, 2005 (74) 1 (1158) 237 150 28.3 1.58
Lowenstein, 1960 (a) (81) 2 (59) 235 148 15.2 1.59
Zachau-Christiansen, 1962 (101) 3 (365) 177 111 17 1.59
Jacquemyn, 2014 (73) 3 (78) 244 150 13 1.63
Bjørke Monsen, 2001 (54) 3 (169) 2452 150 15 1.63
Whiteside, 1968 (b) (98) 2 (50) 127 74 25 1.72
Murphy, 2007 (a) (85) 1 (88) 267 150 0 1.78
Colman, 1975 (58) 3 (106) 524 295 0.9 1.78
Takimoto, 2007 (b) (96) 3 (82) 265 148 16 1.79
Gibson, 2008 (62) 3 (83) 2682 150 23 1.79
Cole, 1974 (57) 3 (130) 272 148 12.3 1.84
Pagán, 2002 (b) (87) 3 (285) 285 148 2.1 1.93
Wu, 2013 (a) (99) 2 (264) 287 148 10 1.94
Ray, 2008 (90) 1 (2490) 249 125 8.5 1.99
Takimoto, 2007 (a) (96) 2 (77) 301 148 8 2.03
Ho, 1987 (69) 3 (221) 229 110 3.6 2.08
Knight, 1991 (b) (76) 3 (75) 318 148 11.2 2.15
Pagán, 2002 (a) (87) 2 (285) 357 148 0.35 2.41
Jacob, 1976 (72) 2 (182) 303 111 4.5 2.73
Whiteside, 1968 (a) (98) 1 (56) 217 74 5 2.93
Black, 1994 (55) 3 (85) 228 74 15 3.08
Marzan, 1971 (a) (83) 2 (100) 270 59 1.5 4.58
Marzan, 1971 (b) (83) 3 (57) 286 59 0 4.85
1The relations between the calculated standardized score (mean vitamin B-12 deficiencyO cutoff value) and corresponding vitamin B-12 insufficiency
rate (n = 57 pairs of results) are shown. The studies are presented according to the standardized score for ease of comparison. The lowercase letters in
parentheses in the first column indicate the order of appearance in the table for studies that reported results from .1 trimester.
2Mean estimated from the median (39).
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such as those from India, Nepal, Turkey, Greece, and parts of South
America. The high rates in the studies from the Indian subcontinent
can be explained by a predominantly vegetarian diet (79).
However, we also found high rates of vitamin B-12 in-
sufficiency in 4 studies from Turkey and in 1 study from Greece
(28, 52, 65, 77, 93). The “Mediterranean diet” contains plenty of
fruit, vegetables, and pulses compared with meat (118), which
may in part explain this observation because stricter adherence
to the diet during pregnancy exacerbated vitamin B-12 de-
ficiency (52). In addition, obesity rates are high in these regions
(119), and obesity has been shown to be associated with low
vitamin B-12 (79, 120–122). The link between obesity, gesta-
tional diabetes, and low vitamin B-12 concentrations has not
been fully explored, but because the former 2 conditions are
independently associated with fetal macrosomia, they may
partly compensate for or mask the associations between vitamin
B-12 and LBW (123, 124).
Plausible reasons for the observed decrease in vitamin B-12
during pregnancy are hemodilution, active transport to the fetus,
and changes in binding proteins (56, 125). Holotranscobalamin,
the functional form of vitamin B-12, is positively correlated with
total cobalamin and the 2 biomarkers negatively correlate with
methylmalonic acid (a marker of tissue-level vitamin B-12 in-
sufficiency) during pregnancy (85). Although serum cobalamin
decreases across the trimesters, holotranscobalamin has been
shown to decrease in some studies and remain unchanged in
others (85, 126). Therefore, the decrease in cobalamin may be
due to a reduction in the fraction bound to haptocorrin (holo-
haptocorin) (126). The tissue-level effects and clinical implica-
tions of a decrease in holo-haptocorin during pregnancy are
unknown and warrant further studies.
Vitamin B-12 insufficiency and BW
Our review showed that the OR of LBW is 1.7 when vitamin
B-12 insufficiency was present in maternal or cord blood (Figure
5). However, our results cannot confirm the association between
low vitamin B-12 and LBWacross the world because any positive
observations may be isolated to Indian populations. Although all
of the studies adjusted for most of the known confounding
factors, the overall effect was driven by 1 study in India (25). It is
important to note that only 27% of the women recruited into the
study had vitamin B-12 concentrations measured, although the
authors reported that they did not differ from the study population
in their baseline characteristics. The 3 results from this study
contributed a total of 21.5% to the pooled results (Figure 5), and
when they were removed from the analysis the OR decreased
from 1.70 to 1.23 (95% CI: 0.90, 1.67). Given the potential
importance of the problem, further studies are needed to replicate
or refute the magnitude of association found in this study.
TABLE 3
Odds of SGA or LBW with low vitamin B-12 concentrations1
First author,
year (reference) Country Trimester2
Vitamin B-12
threshold
Birth outcome
threshold
Cases,
n
Controls,
n OR (95% CI) Adjustments
Muthayya, 2006 (a) (25) India 1 Tertile 1 vs tertile 3
(median: 116 vs 224
pmol/L)
IUGR: ,10th
centile for GA
45 45 5.98 (1.72, 20.74) Maternal age,
education,
parity, weight
Dwarkanath, 2013 (a) (60) India 1 Tertile 1 vs tertile 3
(median: 118 vs 284
pmol/L)
SGA: ,10th
centile for GA
107 103 1.43 (1.02, 2.17) Age, education,
parity, weight,
energy intake
Muthayya, 2006 (b) (25) India 2 Tertile 1 vs tertile 3
(median: 113 vs 210
pmol/L)
IUGR: ,10th
centile for GA
50 54 9.28 (2.90, 29.68) Maternal age,
education,
parity, weight
Furness, 2013 (23) Australia 2 N/R EFW: ,10th
centile and
serial tapering
down of
abdominal
circumference
21 63 1.001 (0.996, 1.006) Folate,
homocysteine,
age, smoking,
BMI, DNA
damage
markers (e.g.,
micronuclei,
nucleoplasmic
bridges)
Dwarkanath, 2013 (b) (60) India 2 Tertile 1 vs tertile 3
(median: 108 vs 245
pmol/L)
SGA: ,10th
centile for GA
96 96 1.45 (0.92, 2.27) Age, education,
parity, weight,
energy intake
Muthayya, 2006 (c) (25) India 3 Tertile 1 vs tertile 3
(median: 111 vs 182
pmol/L)
IUGR: ,10th
centile for GA
49 53 2.81 (1.01. 7.87) Maternal age,
education,
parity, weight
Hogeveen, 2010 (24) Netherlands 3 ,134 pmol/L (Q1) LBW: ,3075 g
(Q1)
92 274 0.70 (0.44, 1.11) GA, smoking, sex
Sukla, 2013 (114) India Cord blood N/R LBW: ,2500 g 138 196 2.41 (1.34, 4.5) N/R
1Study characteristics and results from studies that describe an association between maternal or cord blood vitamin B-12 and birth outcomes by ORs are
shown (n = 5 studies, 8 results). The studies are presented according to the trimester of pregnancy. The lowercase letters in parentheses in the first column
indicate the order of appearance in the table for studies that reported results from .1 trimester. EFW, estimated fetal weight; GA, gestational age; IUGR,
intrauterine growth restriction; LBW, low birth weight; N/R, not reported; Q1, quartile 1; SGA, small-for-gestational age.
2Refers to trimester of maternal vitamin B-12 unless specified as cord blood.
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With regard to the 2 studies from Australia and Holland with
negative results, it is notable that, when compared with the Indian
studies, maternal vitamin B-12 concentrations in the Australian
study were considerably higher (median: 239 pmol/L), whereas
in the Dutch study a higher threshold was used to define LBW
(,3075 g). In addition, the population characteristics differed
[e.g., mean BMI (in kg/m2) of women in the Australian study
(23) was 28.5 compared with 22.0 in the Indian studies (25, 60)],
TABLE 4
Differences in vitamin B-12 concentrations between NBW and adverse-BW outcomes1
First author, year (reference) Country Trimester2
Adverse-BW outcome
threshold
Adverse-BW outcome NBW outcome
n Vitamin B-12, pmol/L n Vitamin B-12, pmol/L
Muthayya, 2006 (a) (25) India 1 LBW: ,2500 g; NBW:
.3000 g
16 156 6 653 39 173 6 58
Ubeda, 2011 (a) (115) Spain 1 IUGR: BW ,10th centile
for GA
7 227.5 6 132.4 48 260.4 6 124.8
McGarry, 1972 (111) UK 2 LBW: ,2500 g; NBW:
.2950 g
14 120 6 33 331 136 6 53
Muthayya, 2006 (b) (25) India 2 LBW: ,2500 g; NBW:
.3000 g
19 139 6 33 44 163 6 46
Ubeda, 2011 (b) (115) Spain 2 IUGR: BW ,10th centile
for GA
7 194.6 6 75.9 48 209.5 6 105.8
Furness, 2013 (23) Australia 2 IUGR: EFW ,10th
centile and serial
tapering down of
abdominal circumference
21 205 6 87.9 63 243 6 135
Krishnaveni, 2014 (108) India 2 LBW: ,2500 g 126 191 6 93 528 186 6 102
Baker, 1977 (a) (104) USA 3 LBW: ,2500 g 50 95 6 13 50 78 6 13
Navarro, 1984 (a) (112) France 3 LBW: ,2500 g 31 295 6 90 26 311 6 58
Abbas, 1994 (a) (102) UK 3 IUGR: abdominal
circumference and
EFW ,5th centile
20 0.1 (0.21)4 20 N/A
Lindblad, 2005 (a) (109) Pakistan 3 IUGR: EFW #11% 46 96 6 415 82 108 6 485
Yajnik, 2005 (116) India 3 SGA: ,10th centile for
sex and GA
30 106 (87, 128)6 50 124 (100, 150)6
Mamabolo, 2006 (110) South Africa 3 Tertile 1 vs tertile 3 66 176 6 74 75 175 6 78
Muthayya, 2006 (c) (25) India 3 LBW: ,2500 g; NBW:
.3000 g
19 137 6 38 42 156 6 45
Ubeda, 2011 (c) (115) Spain 3 IUGR: BW ,10th centile
for GA
7 139.9 6 44.0 48 161.0 6 95.6
Abraham, 2013 (103) India 3 LBW: ,2500 g 58 207 6 94 58 203 6 87
Baker, 1977 (b) (104) USA Cord blood LBW: ,2500 g 50 281 6 43 50 439 6 35
Navarro, 1984 (b) (112) France Cord blood LBW: ,2500 g 32 223 6 61 26 255 6 56
Abbas, 1994 (b) (102) UK Cord blood IUGR: abdominal
circumference and
EBW ,5th centile
20 0.9 (0.28)4 20 N/A
Lindblad, 2005 (b) (109) Pakistan Cord blood IUGR: EFW #11% 46 190 6 1425 82 171 6 815
Muthayya, 2006 (d) (25) India Cord blood LBW: ,2500 g; NBW:
.3000 g
20 195 6 63 47 236 6 94
Gomes, 2010 (106) Sri Lanka Cord blood
(preterm
infants)
SGA: BW ,10th centile
for GA and sex
96 394 6 169.3 113 409 6 224.5
Hay, 2010 (a) (107) Norway Cord blood
(nulliparous)
Quartile 1 vs quartile 4 180 363 (341, 420)7 180 242 (221, 311)7
Hay, 2010 (b) (107) Norway Cord blood
(multiparous)
Quartile 1 vs quartile 4 180 365 (301, 423)7 180 258 (224, 297)7
Sukla, 2013 (114) India Cord blood LBW: ,2500 g 138 142.4 6 60.5 196 157.9 6 53.9
1Characteristics and results from studies that describe mean maternal or cord blood vitamin B-12 concentrations in adverse-BW and NBW outcome groups
are shown (n = 15 studies, 25 results). The studies are presented according to trimester of pregnancy. The lowercase letters in parentheses in the first column
indicate the order of appearance in the table for studies that reported results from .1 trimester. BW, birth weight; EFW, estimated fetal weight; GA, gestational
age; IUGR, intrauterine growth restriction; LBW, low birth weight; N/A, not applicable; NBW, normal birthweight; SGA, small-for-gestational age.
2Refers to trimester of maternal vitamin B-12 unless specified as cord blood.
3Mean 6 SD (all such values).
4Mean difference in SD between cases and controls; SEM in parentheses.
5Mean 6 SD estimated from median (range) (39).
6Geometric mean; 25th, 75th centile in parentheses.
7Geometric mean; 95% CI in parentheses.
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which may have influenced their risk of having LBW/SGA
infants.
In the studies that reported mean concentrations of vitamin
B-12, a nonsignificant trend of lower concentrations was ob-
served in women who delivered LBW or SGA infants, with
a larger effect size found in the first and second compared with the
third trimester. Because the heterogeneity between the studies
was high and there were differences in the populations and vi-
tamin B-12 assays, it was not possible to make meaningful
conclusions with regard to a vitamin B-12 “threshold” that would
be associated with lower fetal BW. In the 2 studies that reported
results from .1 trimester (25, 115), the difference in maternal
vitamin B-12 between normal-BW and LBW infants was greater
in the first or second trimester than in the third trimester (233
compared with221 pmol/L and224 compared with219 pmol/L,
respectively), suggesting that lower vitamin B-12 status earlier in
pregnancy may be more detrimental for offspring weight.
The link between exposure to low vitaminB-12 conditions during
pregnancy, BW, and noncommunicable diseases in the offspring can
be explained by the DOHaD (Developmental Origins of Health and
Disease) hypothesis, which suggests that the fetus is programmed to
adapt to its in utero environment and disease can result if this is
altered (1). The epigenetic modifications associated with low vi-
tamin B-12 concentrations influence placental development from
the early embryonic stage, so it is possible that vitamin B-12 has an
effect on fetal growth and BW through this mechanism (127, 128).
Vitamin B-12 also plays an important role in themyelination of fetal
neurons, whichmaximally occurs frommidgestation until 2 y of age
(129). Hence, the critical window for vitamin B-12 adequacy
continues throughout pregnancy and lactation.
Previous studies have shown an independent inverse re-
lation between maternal homocysteine concentrations and
LBW (OR: 1.25; B-coefficient: 231 g per 1 SD increase in
homocysteine) (130) and hyperhomocysteinemia has been
causally linked to LBW (131). In our prevalence subreview,
14 of the 57 studies reported homocysteine concentrations
(19, 29, 53, 54, 62, 66, 75, 84, 87, 88, 92, 96, 97, 99). Although
a detailed discussion of the associations between vitamin B-12
TABLE 5
Effect of vitamin B-12 concentrations across the spectrum on BW1
First author, year (reference) Country Trimester2 n Unit vitamin B-12 Effect size P Adjustments
Relton, 2005 (a) (113) UK 1 500 1 unit log vitamin
B-12 (pg/mL)
b = 0.033
(20.05, 0.12)
0.41 None
Takimoto, 2007 (a) (96) Japan 1 51 1 pmol/L B = 21.05 0.08 Age, parity, BMI
Pagán, 2002 (a) (87) USA 2 285 1 pmol/L B = 20.2 0.52 GA, race, BMI,
smoking, sex
Takimoto, 2007 (b) (96) Japan 2 77 1 pmol/L B = 25.35 0.38 Age, parity, BMI
Faintuch, 2009 (105) Brazil 2 (post–bariatric
surgery)
13 1 pg/mL r = 20.846 ,0.001 None
Frery, 1992 (a) (61) France 3 (all) 188 1 unit log vitamin
B-12
r = 20.05 NS None
3 (smokers) 25 B = 2507 0.03 Parity, ethnicity
Pagán, 2002 (b) (87) USA 3 285 1 pmol/L B = 20.2 0.53 GA, race, BMI,
smoking, sex
Guerra-Shinohara, 2004 (a) (29) Brazil 3 117 1 pmol/L r = 20.05 0.52 None
Takimoto, 2007 (c) (96) Japan 3 82 1 pmol/L B = 0.776 0.44 Age, parity, BMI
Hogeveen, 2010 (24) Netherlands 3 366 1 SD (69 pmol/L) B = 237 (2100, 29) NS Age, GA, parity,
smoking, sex,
folate supplement
Abraham, 2013 (103) India 3 116 1 pmol/L b = 0.22 0.65 Diet, SES
Krishnaveni, 2014 (108) India 3 654 1 SDS unit log
vitamin B-12
b = 1: 0.024
(20.05, 0.10)
NS Sex, gestational age
b = 0.07
(20.003, 0.15)
Above + BMI, GDM,
SES, parity, religion
Fréry, 1992 (b) (61) France Cord blood (all) 154 1 unit log vitamin
B-12
r = 20.16 ,0.04 None
Cord blood
(smokers)
22 B = 2414 0.06 Parity, ethnicity
Guerra-Shinohara, 2004 (b) (29) Brazil Cord blood 117 1 pmol/L r = 20.02 0.80 None
Relton, 2005 (b) (113) UK Cord blood 522 1 unit log vitamin
B-12 (pg/mL)
b = 20.093 (20.17,
20.01)
0.02 None
Muthayya, 2006 (17) India Cord blood (37–
39 wk gestation)
76 1 pg/mL r = 0.28 0.01 None
India Cord blood ($ to
40 wk gestation)
36 1 pg/mL r = 20.13 0.45 None
1Characteristics and results from studies that describe an association between maternal or cord blood vitamin B-12 and birth outcomes by correlation/
regression analysis are shown (n = 10 studies, 19 results). The studies are presented according to trimester of pregnancy. The effect sizes are reported as
unadjusted correlation coefficients (r), standardised (b) or unstandardised (B) regression coefficients with 95% CI in parantheses (if reported). The lowercase
letters in parentheses in the first column indicates the order of appearance in the table for studies that reported results from .1 trimester. BW, birth weight;
GA, gestational age; GDM, gestational diabetes mellitus; SDS, SD score; SES, socioeconomic status.
2Refers to trimester of maternal vitamin B-12 unless specified as cord blood.
3BW z score.
4BW SDS.
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and homocysteine is beyond the scope of this review, it is
notable that among the studies with high vitamin B-12 in-
sufficiency rates (.40%), average homocysteine was .6 mmol/L
(19, 66, 88); and in 1 study, up to 40% of the women had ho-
mocysteine concentrations .10 mmol/L (92). It is therefore
possible that the association of low vitamin B-12 status and LBW
may be, at least in part, mediated through hyperhomocysteinemia
during pregnancy.
In the absence of folate deficiency, vitamin B-12 deficiency is
the strongest driver of high homocysteine concentrations (132).
FIGURE 5 Meta-analysis of ORs of adverse BW in low maternal (or cord) vitamin B-12 cases and controls (n = 8 results). The letters in parentheses after
the study ID refer to results from different trimesters within each study. The solid diamond represents the pooled OR, and the solid squares in each study
denote the OR for that study (horizontal lines represent 95% CIs). Pooled and heterogeneity analyses were conducted on log-transformed ORs by using
a random-effects model. The pooled OR (95% CI) was 1.70 (1.16, 2.50). *Vitamin B-12 measured in cord blood. BW, birth weight; IV, inverse variance.
FIGURE 6 Meta-analysis of differences in mean vitamin B-12 concentrations between adverse- and normal-birth-weight infants. (A) Vitamin B-12
measured in maternal blood (divided in subgroups according to trimester of pregnancy; n = 14 results) and (B) vitamin B-12 measured in cord blood (n = 6
results). Solid diamonds represent the pooled difference for each subgroup and overall, and the squares in each study denote the mean difference for that study
(horizontal lines represent 95% CIs). The I2 values refer to the statistical heterogeneity within each subgroup and overall. Studies that have reported results
from .1 trimester have a lowercase letter in parentheses in the study reference to indicate their order of appearance in the Forest plots. A random-effects
model using generic inverse variance showed a pooled mean difference (95% CI) of 29.12 (221.25, 3.01) in pregnancy and of 241.51 (2107.96, 24.93) in
cord blood between adverse- and normal-birth-weight infants. IV, inverse variance.
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In 12 studies with high rates of vitamin B-12 insufficiency, folate
deficiency was ,10% (19, 52, 55, 62, 63, 66, 70, 75, 77, 79, 88,
93). This observation was possibly due to adequate dietary in-
take (19, 88, 93) and antenatal consumption of folic acid (52, 66,
75). This imbalance between vitamin B-12 and folate is associ-
ated with lower neonatal BW and anthropometric measurements
(133) as well as insulin resistance in offspring (19). Therefore, it
is essential to address maternal vitamin B-12 status in addition to
folate during pregnancy.
A meta-analysis of multiple micronutrient supplementation
trials (typically containing 1 Recommended Daily Allowance of
vitamin B-12) conducted in 12 low-income countries showed that
supplementation was associated with a modest increase in BW
(effect size: +22 g; P = 0.002) and reduced rates of LBW and
SGA (134). Although this may not be due to optimizing con-
centrations of vitamin B-12 per se, it suggests that micro-
nutrients in general are likely to contribute to increasing BW.
Folic acid supplementation has been associated with higher BW,
supporting the above explanation (135, 136).
The strengths of our study are that this is the first review, to our
knowledge, to consider the vitamin B-12 status of pregnant
women on a global level and link this to BW. We were able to
show patterns in vitamin B-12 insufficiency rates and associations
with BW in populations who broadly share dietary habits and
inherent risk, although other differences may exist. One key
limitation of our report is the vast heterogeneity between the
studies in terms of vitamin B-12 measurement assays and cutoffs.
This was partly addressed by devising the “standardized score,”
which allowed comparisons to be made between the studies after
controlling for geographic region, trimester, and assay type.
Another limitation is that, despite the large number of studies,
the numbers were small in the subgroups (e.g., individual tri-
mesters), highlighting the need for adequately powered longi-
tudinal cohort studies with LBW or SGA as outcomes.
Conclusions
Our systematic review and meta-analysis in pregnant women
showed that rates of vitamin B-12 insufficiency are high in certain
populations (e.g., the Indian subcontinent and Eastern Medi-
terranean), including in nonvegetarian populations. The possible
association between vitamin B-12 insufficiency and LBW/SGA
warrants further investigation through larger cohort studies and
randomized controlled trials. Even if the effect size of maternal
vitamin B-12 on BW is modest, it has the potential to influence
the health of future generations if a link is proven. The results of
further studies will dictate practice with regard to vitamin B-12
supplementation in preconception and pregnancy, but until then,
it would be sensible at least to measure vitamin B-12 concen-
trations when pregnant women first present to antenatal facilities
across the world.
We thank N Bawazeer and S Ayre for assisting with the initial database
searches and selection of eligible articles for the prevalence subreview.
The authors’ responsibilities were as follows—NS: performed the data-
base searches, data extraction, and statistical analysis and wrote the manu-
script; SBR: assisted with the database searches and data extraction and
reviewed the manuscript; N-BK: performed the statistical analysis; RB and
CSY: reviewed the manuscript for intellectual content; PS: conceived the
study, participated in its design, and helped to draft the manuscript; and all
authors: read and approved the final manuscript. The authors declared that
they had no competing interests.
REFERENCES
1. Yajnik CS, Deshmukh US. Fetal programming: maternal nutrition and
role of one-carbon metabolism. Rev Endocr Metab Disord 2012;13:
121–7.
2. Saravanan P, Yajnik CS. Role of maternal vitamin B12 on the met-
abolic health of the offspring: a contributor to the diabetes epidemic?
Br J Diabetes Vasc Dis 2010;10:109–14.
3. Smith AD, Kim Y-I, Refsum H. Is folic acid good for everyone? Am J
Clin Nutr 2008;87:517–33.
4. Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide prob-
lem. Annu Rev Nutr 2004;24:299–326.
5. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM.
Folate, vitamin B12, and serum total homocysteine levels in con-
firmed Alzheimer disease. Arch Neurol 1998;55:1449–55.
6. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alz-
heimer’s disease as revealed by serum holotranscobalamin. J Neurol
Neurosurg Psychiatry 2003;74:959–61.
7. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative
assessment of plasma homocysteine as a risk factor for vascular
disease: probable benefits of increasing folic acid intakes. JAMA
1995;274:1049–57.
8. Homocysteine Studies C. Homocysteine and risk of ischemic heart
disease and stroke: a meta-analysis. JAMA 2002;288:2015–22.
9. Rafnsson SB, Saravanan P, Bhopal RS, Yajnik CS. Is a low blood
level of vitamin B12 a cardiovascular and diabetes risk factor? A
systematic review of cohort studies. Eur J Nutr 2011;50:97–106.
10. George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath
F, Cnattingius S. Plasma folate levels and risk of spontaneous abor-
tion. JAMA 2002;288:1867–73.
11. Mujawar SA, Patil VW, Daver RG. Study of serum homocysteine,
folic acid and vitamin B(12) in patients with preeclampsia. Indian J
Clin Biochem 2011;26:257–60.
12. Sanchez SE, Zhang C, Rene Malinow M, Ware-Jauregui S, Larrabure
G, Williams MA. Plasma folate, vitamin B(12), and homocyst(e)ine
concentrations in preeclamptic and normotensive Peruvian women.
Am J Epidemiol 2001;153:474–80.
13. Ronnenberg AG, Goldman MB, Chen D, Aitken IW, Willett WC,
Selhub J, Xu X. Preconception homocysteine and B vitamin status
and birth outcomes in Chinese women. Am J Clin Nutr 2002;76:
1385–91.
14. de Jong-van den Berg LT. Monitoring of the folic acid supplemen-
tation program in the Netherlands. Food Nutr Bull 2008;29(2 Suppl):
S210–3.
15. Centers for Disease Control and Prevention. Spina bifida and anen-
cephaly before and after folic acid mandate— United States, 1995–
1996 and 1999–2000. MMWR Morb Mortal Wkly Rep 2004;53:
362e–5.
16. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong
PY, Farrell SA, Cole DE. Vitamin B12 and the risk of neural tube
defects in a folic-acid-fortified population. Epidemiology 2007;18:
362–6.
17. Muthayya S, Dwarkanath P, Mhaskar M, Mhaskar R, Thomas A,
Duggan C, Fawzi WW, Bhat S, Vaz M, Kurpad A. The relationship of
neonatal serum vitamin B12 status with birth weight. Asia Pac J Clin
Nutr 2006;15:538–43.
18. Adaikalakoteswari A, Vatish M, Lawson A, Wood C, Sivakumar K,
McTernan PG, Webster C, Anderson N, Yajnik CS, Tripathi G, et al.
Low maternal vitamin B12 status is associated with lower cord blood
HDL cholesterol in white caucasians living in the UK. Nutrients
2015;7:2401–14.
19. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ,
Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, et al. Vitamin B12 and
folate concentrations during pregnancy and insulin resistance in the off-
spring: the Pune Maternal Nutrition Study. Diabetologia 2008;51:29–38.
20. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull
2001;60:5–20.
21. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S,
Barrett-Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, et al.
Birth weight and risk of type 2 diabetes: a systematic review. JAMA
2008;300:2886–97.
22. Yajnik CS, Fall CH, Vaidya U, Pandit AN, Bavdekar A, Bhat DS,
Osmond C, Hales CN, Barker DJ. Fetal growth and glucose and in-
sulin metabolism in four-year-old Indian children. Diabet Med 1995;
12:330–6.
B-12 INSUFFICIENCY IN PREGNANCY AND BIRTH WEIGHT 17 of 20
23. Furness D, Fenech M, Dekker G, Khong TY, Roberts C, Hague W.
Folate, vitamin B12, vitamin B6 and homocysteine: impact on
pregnancy outcome. Matern Child Nutr 2013;9:155–66.
24. Hogeveen M, Blom HJ, van der Heijden EH, Semmekrot BA, Sporken
JM, Ueland PM, den Heijer M. Maternal homocysteine and related B
vitamins as risk factors for low birthweight. Am J Obstet Gynecol
2010;202(6):572e1–5.
25. Muthayya S, Kurpad AV, Duggan CP, Bosch RJ, Dwarkanath P,
Mhaskar A, Mhaskar R, Thomas A, Vaz M, Bhat S, et al. Low ma-
ternal vitamin B12 status is associated with intrauterine growth re-
tardation in urban South Indians. Eur J Clin Nutr 2006;60:791–801.
26. UNICEF; WHO. Low birthweight: country, regional and global es-
timates. New York: UNICEF; 2004.
27. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L,
Guttormsen AB, Joglekar A, Sayyad MG, Ulvik A, et al. Hyper-
homocysteinemia and elevated methylmalonic acid indicate a high
prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr
2001;74:233–41.
28. Ac¸kurt F, Wetherilt H, Lo¨ker M, Hacibekirolu M. Biochemical as-
sessment of nutritional status in pre-and post-natal Turkish women
and outcome of pregnancy. Eur J Clin Nutr 1995;49:613–22.
29. Guerra-Shinohara EM, Morita OE, Peres S, Pagliusi RA, Neto LFS,
D’Almeida V, Irazusta SP, Allen RH, Stabler SP. Low ratio of S-
adenosylmethionine to S-adenosylhomocysteine is associated with
vitamin deficiency in Brazilian pregnant women and newborns. Am J
Clin Nutr 2004;80:1312–21.
30. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D,
Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of obser-
vational studies in epidemiology: a proposal for reporting. Meta-
analysis of Observational Studies in Epidemiology (MOOSE) group.
JAMA 2000;283:2008–12.
31. García-Casal MN, Osorio C, Landaeta M, Leets I, Matus P, Fazzino F,
Marcos E. High prevalence of folic acid and vitamin B12 deficiencies
in infants, children, adolescents and pregnant women in Venezuela.
Eur J Clin Nutr 2005;59:1064–70.
32. Cikot RJ, Steegers-Theunissen RP, Thomas CM, de Boo TM, Merkus
HM, Steegers EA. Longitudinal vitamin and homocysteine levels in
normal pregnancy. Br J Nutr 2001;85:49–58.
33. Van Sande H, Jacquemyn Y, Karepouan N, Ajaji M. Vitamin B12 in
pregnancy: Maternal and fetal/neonatal effects—a review. Open J
Obstet Gynecol 2013;3:599–602.
34. McLean E, de Benoist B, Allen LH. Review of the magnitude of
folate and vitamin B12 deficiencies worldwide. Food Nutr Bull 2008;
29(2 Suppl):S38–51.
35. Goldenberg RL, Cliver SP. Small for gestational age and intrauterine
growth restriction: definitions and standards. Clin Obstet Gynecol
1997;40:704–14.
36. Higgins JPT, Green S. Cochrane handbook for systematic reviews
of interventions [cited 2012 Jan]. Available from: http://www.
cochrane-handbook.org.
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin
Trials 1986;7:177–88.
38. StataCorp. Stata Statistical software: release 12. College Station
(TX): StataCorp LP; 2011.
39. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance
from the median, range, and the size of a sample. BMC Med Res
Methodol 2005;5–13.
40. IBM Corporation. IBM SPSS Statistics for Windows, version 22.0.
Armonk (NY): IBM Corporation; 2013.
41. Review Manager (RevMan). Version 5.3. Copenhagen (Denmark):
The Nordic Cochrane Centre, The Cochrane Collaboration; 2013.
42. Scottish Intercollegiate Guidelines Network; Healthcare Improvement
Scotland. 2014 [Internet] [cited 2015 May 31]. SIGN 50: a guideline
developer’s handbook. Available from: http://www.sign.ac.uk.
43. Ball EW, Giles C. Folic acid and vitamin B12 levels in pregnancy and
their relation to megaloblastic anaemia. J Clin Pathol 1964;17:165–
74.
44. Bondevik GT, Schneede J, Refsum H, Lie RT, Ulstein M, Kvale G.
Homocysteine and methylmalonic acid levels in pregnant Nepali
women: should cobalamin supplementation be considered? Eur J Clin
Nutr 2001;55:856–64.
45. Ipciglu OM, Gultepe M, Ozcan O. Cobalamin deficiency during
pregnancy expressed as elevated urine methylmalonic acid levels
determined by a photometric assay. Turk J Med Sci 2007;37:139–43.
46. Vanderjagt DJ, Brock HS, Melah GS, El-Nafaty AU, Crossey MJ,
Glew RH. Nutritional factors associated with anaemia in pregnant
women in northern Nigeria. J Health Popul Nutr 2007;25:75–81.
47. Brabin BJ, van den Berg H, Nijmeyer F. Folacin, cobalamin, and
hematological status during pregnancy in rural Kenya: the influence
of parity, gestation, and Plasmodium falciparum malaria. Am J Clin
Nutr 1986;43:803–15.
48. Haliloglu B, Aksungar FB, Celik A, Ilter E, Coksuer H, Ozekici U.
Negative correlation between D-dimer and homocysteine levels dur-
ing pregnancy and the postpartum period: a prospective study. Eur J
Obstet Gynecol Reprod Biol 2010;153:23–6.
49. Abdelrahim II, Adam GK, Mohmmed AA, Salih MM, Ali NI, El-
bashier MI, Adam I. Anaemia, folate and vitamin B12 deficiency
among pregnant women in an area of unstable malaria transmission in
eastern Sudan. Trans R Soc Trop Med Hyg 2009;103:493–6.
50. Areekul S, Ukoskit K, Yamarat P, Panatampon P, Tanapongpipatana
S. Prevalence of anaemia in pregnant Thai women. J Med Assoc Thai
1976;59:525–31.
51. Baker H, Frank O, Thomson AD, Langer A, Munves ED, De Angelis
B, Kaminetzky HA. Vitamin profile of 174 mothers and newborns at
parturition. Am J Clin Nutr 1975;28:59–65.
52. Balcı YI, Ergin A, Karabulut A, Polat A, Dogan M, Kucuktasci K.
Serum vitamin B12 and folate concentrations and the effect of the
Mediterranean diet on vulnerable populations. Pediatr Hematol Oncol
2014;31:62–7.
53. Barbosa PR, Stabler SP, Machado ALK, Braga RC, Hirata RDC, Hirata
MH, Sampaio-Neto LF, Allen RH, Guerra-Shinohara EM. Association
between decreased vitamin levels and MTHFR, MTR and MTRR gene
polymorphisms as determinants for elevated total homocysteine con-
centrations in pregnant women. Eur J Clin Nutr 2008;62:1010–21.
54. Bjørke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB,
Markestad T, Solheim E, Refsum H. Determinants of cobalamin
status in newborns. Pediatrics 2001;108:624–30.
55. Black AK, Allen LH, Pelto GH, de Mata MP, Chávez A. Iron, vi-
tamin B12 and folate status in Mexico: associated factors in men
and women and during pregnancy and lactation. J Nutr 1994;124:
1179–88.
56. Bruinse HW, van den Berg H. Changes of some vitamin levels during
and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1995;
61:31–7.
57. Cole JK, Kimber RJ, Kutkaite D. Serum folic acid levels and preg-
nancy in South Australia: a study of the factors associated with low
serum folic acid levels with particular reference to racial groups and
lactation. Med J Aust 1974;1:421–4.
58. Colman N, Barker EA, Barker M, Green R, Metz J. Prevention of
folate deficiency by food fortification. IV. Identification of target
groups in addition to pregnant women in an adult rural population.
Am J Clin Nutr 1975;28:471–6.
59. Cook JD, Alvarado J, Gutnisky A, Jamra M, Labardini J, Layrisse M,
Linares J, Loria A, Maspes V, Restrepo A, et al. Nutritional deficiency and
anemia in Latin America: a collaborative study. Blood 1971;38:591–603.
60. Dwarkanath P, Barzilay JR, Thomas T, Thomas A, Bhat S, Kurpad
AV. High folate and low vitamin B-12 intakes during pregnancy are
associated with small-for-gestational age infants in South Indian
women: a prospective observational cohort study. Am J Clin Nutr
2013;98:1450–8.
61. Fréry N, Huel G, Leroy M, Moreau T, Savard R, Blot P, Lellouch J.
Vitamin B12 among parturients and their newborns and its relationship
with birthweight. Eur J Obstet Gynecol Reprod Biol 1992;45:155–63.
62. Gibson RS, Abebe Y, Stabler S, Allen RH, Westcott JE, Stoecker BJ,
Krebs NF, Michael K. Zinc, gravida, infection, and iron, but not vi-
tamin B-12 or folate status, predict hemoglobin during pregnancy in
southern Ethiopia. J Nutr 2008;138:581–6.
63. Giugliani ER, Jorge SM, Goncalves AL. Folate and vitamin B12
deficiency among parturients from Porto Alegre, Brazil. Rev Invest
Clin 1984;36:133–6.
64. Goedhart G, van der Wal MF, van Eijsden M, Bonsel GJ. Maternal
vitamin B-12 and folate status during pregnancy and excessive infant
crying. Early Hum Dev 2011;87:309–14.
65. Halicioglu O, Sutcuoglu S, Koc F, Ozturk C, Albudak E, Colak A,
Sahin E, Asik Akman S. Vitamin B12 and folate statuses are asso-
ciated with diet in pregnant women, but not with anthropometric
measurements in term newborns. J Matern Fetal Neonatal Med 2012;
25:1618–21.
18 of 20 SUKUMAR ET AL.
66. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, Van Geen
A, Yunus M, Rahman M, Pilsner J. Determinants of arsenic metab-
olism: blood arsenic metabolites, plasma folate, cobalamin, and ho-
mocysteine concentrations in maternal–newborn pairs. Environ
Health Perspect 2007;115:1503–9.
67. Heppe DH, Medina-Gomez C, Hofman A, Franco OH, Rivadeneira F,
Jaddoe VW. Maternal first-trimester diet and childhood bone mass:
the Generation R Study. Am J Clin Nutr 2013;98:224–32.
68. Hinderaker SG, Olsen BE, Lie RT, Bergsjo PB, Gasheka P, Bondevik
GT, Ulvik R, Kvale G. Anemia in pregnancy in rural Tanzania: as-
sociations with micronutrients status and infections. Eur J Clin Nutr
2002;56:192–9.
69. Ho CH, Yuan CC, Yeh SH. Serum ferritin, folate and cobalamin levels
and their correlation with anemia in normal full-term pregnant
women. Eur J Obstet Gynecol Reprod Biol 1987;26:7–13.
70. House JD, March SB, Ratnam S, Ives E, Brosnan JT, Friel JK. Folate
and vitamin B12 status of women in Newfoundland at their first
prenatal visit. CMAJ 2000;162:1557–9.
71. Hussein L, Sahar Abdel A, Tapouzada S, Boehles H. Serum vitamin
B12 concentrations among mothers and newborns and follow-up
study to assess implication on the growth velocity and the urinary
methylmalonic acid excretion. Int J Vitam Nutr Res 2009;79:297–307.
72. Jacob M, Hunt I, Dirige O, Swendseid M. Biochemical assessment of
the nutritional status of low-income pregnant women of Mexican
descent. Am J Clin Nutr 1976;29:650–6.
73. Jacquemyn Y, Ajaji M, Karepouan N. Vitamin D levels in maternal
serum and umbilical cord blood in a multi-ethnic population in
Antwerp, Belgium. Facts Views Vis ObGyn 2013;5:3–5.
74. Jiang T, Christian P, Khatry SK, Wu L, West KP Jr. Micronutrient
deficiencies in early pregnancy are common, concurrent, and vary by
season among rural Nepali pregnant women. J Nutr 2005;135:1106–12.
75. Katre P, Bhat D, Lubree H, Otiv S, Joshi S, Joglekar C, Rush E,
Yajnik C. Vitamin B12 and folic acid supplementation and plasma
total homocysteine concentrations in pregnant Indian women with
low B12 and high folate status. Asia Pac J Clin Nutr 2010;19:335–43.
76. Knight EM, Spurlock BG, Johnson AA, Oyemade UJ, Cole OJ, West
WL, Manning MG. Hematologic and vitamin status of African
American women and their relationships to pregnancy outcome. Nutr
Res 1991;11:1357–75.
77. Koc A, Kocyigit A, Soran M, Demir N, Sevinc E, Erel O, Mil Z. High
frequency of maternal vitamin B12 deficiency as an important cause
of infantile vitamin B12 deficiency in Sanliurfa province of Turkey.
Eur J Nutr 2006;45:291–7.
78. Ko¨sxu¨sx N, Ko¨sxu¨s A, Hizli D, Bitirgen EU, Turhan NO. Can serum
ferritin, vitamin B(12) and folic acid levels affect serum screening tests
during pregnancy? J Matern Fetal Neonatal Med 2012;25:1674–7.
79. Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL,
Yajnik CS, Fall CH. Low plasma vitamin B12 in pregnancy is asso-
ciated with gestational ‘diabesity’ and later diabetes. Diabetologia
2009;52:2350–8.
80. Li L, Ekstrom EC, Goessler W, Lonnerdal B, Nermell B, Yunus M,
Rahman A, El S, Persson LA, Vahter M. Nutritional status has mar-
ginal influence on the metabolism of inorganic arsenic in pregnant
Bangladeshi women. Environ Health Perspect 2008;116:315–21.
81. Lowenstein L, Lalonde M, Deschenes EB, Shapiro L. Vitamin B12 in
pregnancy and the puerperium. Am J Clin Nutr 1960;8:265–75.
82. Ma AG, Chen XC, Wang Y, Xu RX, Zheng MC, Li JS. The multiple
vitamin status of Chinese pregnant women with anemia and nonanemia
in the last trimester. J Nutr Sci Vitaminol (Tokyo) 2004;50:87–92.
83. Marzan AM, Tantengco VO, Caviles AP. Nutritional anaemias among
Filipinos during pregnancy. Southeast Asian J Trop Med Public
Health 1971;2:564–74.
84. Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM. Cobalamin
status during normal pregnancy and postpartum: a longitudinal study
comprising 406 Danish women. Eur J Haematol 2006;76:521–5.
85. Murphy MM, Molloy AM, Ueland PM, Fernandez-Ballart JD,
Schneede J, Arija V, Scott JM. Longitudinal study of the effect of
pregnancy on maternal and fetal cobalamin status in healthy women
and their offspring. J Nutr 2007;137:1863–7.
86. Osifo BO, Onifade A. Maternal and foetal vitamin B12 concentration
at parturition among Nigerians. Trop Geogr Med 1976;28:37–40.
87. Pagán K, Hou J, Goldenberg RL, Cliver SP, Tamura T. Mid-
pregnancy serum homocysteine and B-vitamin concentrations and
fetal growth. Nutr Res 2002;22:1133–41.
88. Park H, Kim YJ, Ha EH, Kim KN, Chang N. The risk of folate and
vitamin B(12) deficiencies associated with hyperhomocysteinemia
among pregnant women. Am J Perinatol 2004;21:469–75.
89. Pathak P, Kapil U, Yajnik CS, Kapoor SK, Dwivedi SN, Singh R.
Iron, folate, and vitamin B12 stores among pregnant women in a rural
area of Haryana State, India. Food Nutr Bull 2007;28:435–8.
90. Ray JG, Goodman J, O’Mahoney PRA, Mamdani MM, Jiang D. High
rate of maternal vitamin B12 deficiency nearly a decade after Cana-
dian folic acid flour fortification. QJM 2008;101:475–7.
91. Roberts PD, James H, Petrie A, Morgan JO, Hoffbrand AV. Vitamin B
12 status in pregnancy among immigrants to Britain. BMJ 1973;3:67–72.
92. Samuel TM, Duggan C, Thomas T, Bosch R, Rajendran R, Virtanen
SM, Srinivasan K, Kurpad AV. Vitamin B(12) intake and status in
early pregnancy among urban South Indian women. Ann Nutr Metab
2013;62:113–22.
93. Schulpis K, Spiropoulos A, Gavrili S, Karikas G, Grigori C, Vlachos
G, Papassotiriou I. Maternal–neonatal folate and vitamin B12 serum
concentrations in Greeks and in Albanian immigrants. J Hum Nutr
Diet 2004;17:443–8.
94. Shamim AA, Kabir A, Merrill RD, Ali H, Rashid M, Schulze K,
Labrique A, West KP Jr., Christian P. Plasma zinc, vitamin B(12) and
alpha-tocopherol are positively and plasma gamma-tocopherol is
negatively associated with Hb concentration in early pregnancy in
north-west Bangladesh. Public Health Nutr 2013;16:1354–61.
95. Shields RC, Caric V, Hair M, Jones O, Wark L, McColl MD, Ramsay
JE. Pregnancy-specific reference ranges for haematological variables
in a Scottish population. J Obstet Gynaecol 2011;31:286–9.
96. Takimoto H, Mito N, Umegaki K, Ishiwaki A, Kusama K, Abe S,
Yamawaki M, Fukuoka H, Ohta C, Yoshiike N. Relationship between
dietary folate intakes, maternal plasma total homocysteine and B-vitamins
during pregnancy and fetal growth in Japan. Eur J Nutr 2007;46:300–6.
97. Vanderjagt DJ, Ujah I, Patel A, Kellywood J, Crossey M, Allen R,
Stabler S, Obande O, Glew R. Subclinical vitamin B12 deficiency in
pregnant women attending an antenatal clinic in Nigeria. J Obstet
Gynaecol 2009;29:288–95.
98. Whiteside MG, Ungar B, Cowling D. Iron, folic acid and vitamin B12
levels in normal pregnancy, and their influence on birth-weight and
the duration of pregnancy. Med J Aust 1968;1:338–42.
99. Wu BT, Innis SM, Mulder KA, Dyer RA, King DJ. Low plasma vi-
tamin B-12 is associated with a lower pregnancy-associated rise in
plasma free choline in Canadian pregnant women and lower postnatal
growth rates in their male infants. Am J Clin Nutr 2013;98:1209–17.
100. Yusufji D, Mathan VI, Baker SJ. Iron, folate, and vitamin B 12 nu-
trition in pregnancy: a study of 1000 women from southern India. Bull
World Health Organ 1973;48:15–22.
101. Zachau-Christiansen B, Hoff-Jorgensen HOF, Kristensen KRI. The rel-
ative haemoglobin, iron, vitamin B12 and folic acid values in the blood
of mothers and their newborn infants. Dan Med Bull 1962;9:157–66.
102. Abbas A, Snijders RJ, Nicolaides KH. Serum ferritin and cobalamin
in growth retarded fetuses. Br J Obstet Gynaecol 1994;101:215–9.
103. Abraham A, Mathews JE, Sebastian A, Chacko KP, Sam D. A nested
case-control study to evaluate the association between fetal growth
restriction and vitamin B12 deficiency. Aust N Z J Obstet Gynaecol
2013;53:399–402.
104. Baker H, Thind IS, Frank O, DeAngelis B, Caterini H, Louria DB.
Vitamin levels in low-birth-weight newborn infants and their mothers.
Am J Obstet Gynecol 1977;129:521–4.
105. Faintuch J, Dias MC, de Souza Fazio E, de Oliveira FC, Nomura RM,
Zugaib M, Cecconello I. Pregnancy nutritional indices and birth
weight after Roux-en-Y gastric bypass. Obes Surg 2009;19:583–9.
106. Gomes TS, Lindner U, Tennekoon KH, Karandagoda W, Gortner L,
Obeid R. Homocysteine in small-for-gestational age and appropriate-
for-gestational age preterm neonates from mothers receiving folic
acid supplementation. Clin Chem Lab Med 2010;48:1157–61.
107. Hay G, Clausen T, Whitelaw A, Trygg K, Johnston C, Henriksen T,
Refsum H. Maternal folate and cobalamin status predicts vitamin
status in newborns and 6-month-old infants. J Nutr 2010;140:557–64.
108. Krishnaveni GV, Veena SR, Karat SC, Yajnik CS, Fall CH. Associ-
ation between maternal folate concentrations during pregnancy and
insulin resistance in Indian children. Diabetologia 2014;57:110–21.
109. Lindblad B, Zaman S, Malik A, Martin H, Ekstrom AM, Amu S,
Holmgren A, Norman M. Folate, vitamin B12, and homocysteine
levels in South Asian women with growth-retarded fetuses. Acta
Obstet Gynecol Scand 2005;84:1055–61.
B-12 INSUFFICIENCY IN PREGNANCY AND BIRTH WEIGHT 19 of 20
110. Mamabolo RL, Alberts M, Levitt NS. The effect of maternal glucose
metabolism, iron, vitamin B12 and folate status on pregnancy out-
comes. South Afr J Clin Nutr 2006;19:120–30.
111. McGarry JM, Andrews J. Smoking in pregnancy and vitamin B 12
metabolism. BMJ 1972;2:74–7.
112. Navarro J, Causse MB, Desquilbet N, Herve F, Lallemand D. The
vitamin status of low birth weight infants and their mothers. J Pediatr
Gastroenterol Nutr 1984;3:744–8.
113. Relton CL, Pearce MS, Parker L. The influence of erythrocyte folate and
serum vitamin B12 status on birth weight. Br J Nutr 2005;93:593–9.
114. Sukla KK, Tiwari PK, Kumar A, Raman R. Low birthweight (LBW)
and neonatal hyperbilirubinemia (NNH) in an Indian cohort: associ-
ation of homocysteine, its metabolic pathway genes and micro-
nutrients as risk factors. PLoS One 2013;8:e71587.
115. Ubeda N, Reyes L, Gonzalez-Medina A, Alonso-Aperte E, Varela-
Moreiras G. Physiologic changes in homocysteine metabolism in
pregnancy: a longitudinal study in Spain. Nutrition 2011;27:925–30.
116. Yajnik CS, Deshpande SS, Panchanadikar AV, Naik SS, Deshpande
JA, Coyaji KJ, Fall C, Refsum H. Maternal total homocysteine con-
centration and neonatal size in India. Asia Pac J Clin Nutr 2005;14:
179–81.
117. Obeid R, Munz W, Jager M, Schmidt W, Herrmann W. Biochemical
indexes of the B vitamins in cord serum are predicted by maternal B
vitamin status. Am J Clin Nutr 2005;82:133–9.
118. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A,
Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural
model for healthy eating. Am J Clin Nutr 1995;61(6 Suppl):1402S–6S.
119. Delibasi T, Karaaslan Y, Ustun I, Koroglu E, Hosgor S. National
prevalence of underweight, overweight and obesity in Turkey: cross
sectional study of a representative adult population. CEJMed 2007;2:
294–303.
120. Knight BA, Shields BM, Brook A, Hill A, Bhat DS, Hattersley AT,
Yajnik CS. Lower circulating B12 is associated with higher obesity
and insulin resistance during pregnancy in a non-diabetic white
British population. PLoS One 2015;10:e0135268.
121. Pinhas-Hamiel O, Doron-Panush N, Reichman B, Nitzan-Kaluski D,
Shalitin S, Geva-Lerner L. Obese children and adolescents: a risk
group for low vitamin B12 concentration. Arch Pediatr Adolesc Med
2006;160:933–6.
122. Adaikalakoteswari A, Finer S, Voyias PD, McCarthy CM, Vatish M,
Moore J, Smart-Halajko M, Bawazeer N, Al-Daghri NM, McTernan
PG, et al. Vitamin B12 insufficiency induces cholesterol biosynthesis
by limiting S-adenosylmethionine and modulating the methylation of
SREBF1 and LDLR genes. Clin Epigenetics 2015;7:14.
123. Gaudet L, Ferraro ZM, Wen SW, Walker M. Maternal obesity and
occurrence of fetal macrosomia: a systematic review and meta-analysis.
Biomed Res Int 2014;2014:640291.
124. He XJ, Qin FY, Hu CL, Zhu M, Tian CQ, Li L. Is gestational diabetes
mellitus an independent risk factor for macrosomia: a meta-analysis?
Arch Gynecol Obstet 2015;291:729–35.
125. Koebnick C, Heins UA, Dagnelie PC, Wickramasinghe SN,
Ratnayaka ID, Hothorn T, Pfahlberg AB, Hoffmann I, Lindemans J,
Leitzmann C. Longitudinal concentrations of vitamin B(12) and
vitamin B(12)-binding proteins during uncomplicated pregnancy.
Clin Chem 2002;48:928–33.
126. Greibe E, Andreasen BH, Lildballe DL, Morkbak AL, Hvas AM,
Nexo E. Uptake of cobalamin and markers of cobalamin status:
a longitudinal study of healthy pregnant women. Clin Chem Lab Med
2011;49:1877–82.
127. Koukoura O, Sifakis S, Spandidos DA. DNA methylation in the hu-
man placenta and fetal growth [review]. Mol Med Rep 2012;5:883–9.
128. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at
transposons and imprinted genes, and enhanced susceptibility to adult
chronic diseases. Nutrition 2004;20:63–8.
129. Black MM. Effects of vitamin B12 and folate deficiency on brain
development in children. Food Nutr Bull 2008;29(2 Suppl):S126–31.
130. Hogeveen M, Blom HJ, den Heijer M. Maternal homocysteine and
small-for-gestational-age offspring: systematic review and meta-
analysis. Am J Clin Nutr 2012;95:130–6.
131. Yajnik CS, Chandak GR, Joglekar C, Katre P, Bhat DS, Singh SN,
Janipalli CS, Refsum H, Krishnaveni G, Veena S, et al. Maternal
homocysteine in pregnancy and offspring birthweight: epidemiolog-
ical associations and Mendelian randomization analysis. Int J Epi-
demiol 2014;43:1487–97.
132. Selhub J, Morris MS, Jacques PF. In vitamin B12 deficiency, higher
serum folate is associated with increased total homocysteine and
methylmalonic acid concentrations. Proc Natl Acad Sci USA 2007;
104:19995–20000.
133. Gadgil M, Joshi K, Pandit A, Otiv S, Joshi R, Brenna JT, Patwardhan
B. Imbalance of folic acid and vitamin B12 is associated with birth
outcome: an Indian pregnant women study. Eur J Clin Nutr 2014;68:
726–9.
134. Fall CH, Fisher DJ, Osmond C, Margetts BM; Maternal Micronutrient
Supplementation Study Group. Multiple micronutrient supplementa-
tion during pregnancy in low-income countries: a meta-analysis of
effects on birth size and length of gestation. Food Nutr Bull 2009;30(4
Suppl):S533–46.
135. Christian P, Khatry SK, Katz J, Pradhan EK, LeClerq SC, Shrestha
SR, Adhikari RK, Sommer A, West KP Jr. Effects of alternative
maternal micronutrient supplements on low birth weight in rural
Nepal: double blind randomised community trial. BMJ 2003;326:
571–6.
136. Hodgetts VA, Morris R, Francis A, Gardosi J, Ismail K. Effectiveness
of folic acid supplementation in pregnancy on reducing the risk of
small-for-gestational age neonates: a population study, systematic
review and meta-analysis. BJOG 2015;122:478–90.
20 of 20 SUKUMAR ET AL.
